This report is a health system assessment focused on HIV care services for Venezuelan migrants living in Peru. The assessment reviews secondary data sources; interviews with key informants, users, and professionals who are responsible for health facilities providing Antiretroviral Therapy (HF ART); observes visits to selected HF ART; and provides an overview of a self-administered survey to those responsible for HF ART in the country.

En este informe, LHSS evalúa la demanda de productos básicos para el VIH necesarios para brindar una cobertura adecuada a los venezolanos que viven con el VIH en Perú y analiza los sistemas de pronóstico existentes en el Ministerio de Salud para determinar su precisión en la adquisición y el seguimiento de la distribución de medicamentos clave para el VIH.

In this report, LHSS quantifies the demand for HIV commodities needed to provide adequate coverage for Venezuelans living with HIV in Peru and analyzes existing forecasting systems at the MOH to determine its accuracy in procuring and monitoring the distribution of key HIV drugs.

LHSS tiene como objetivo fortalecer la capacidad del Ministerio de Salud para garantizar la disponibilidad de productos para el VIH (ARV y dispositivos médicos) para la población migrante venezolana en Perú. Como parte de este esfuerzo, LHSS estimó la demanda de productos relacionados con el VIH relacionados con esta población, incluidos detalles como el tipo, la cantidad y el momento. 

This report provides a summary of the results of the quantification of demand for HIV commodities for the Venezuelan migrant population in Peru. It includes the capabilities and limitations of the quantification model, its approach to quantification, and the sources used.

How can countries make progress towards good health budget execution? In this latest blog in our budget execution series, ministry of health practitioners from eight countries offer lessons based on their own experiences and shared learning. 

Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO).  On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.

Through an LHSS-Joint Learning Network learning exchange, health practitioners from seven countries are sharing successful experiences and promising practices to institutionalize explicit national priority-setting processes for health. The goal? To help countries set equitable national health priorities and ensure that these priorities are reflected in national health plans and budgets.

This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.

Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.

Conducted by LHSS, this market analysis examines four factors affecting SHI-covered ARV procurement and supply in Vietnam, and it also summarizes findings and recommendations across each of these factors.

U.S. Charge d’ Affaires Tom Daley and USAID Mission Director Zema Semunegus join the representative from local nongovernmental organizations and the Ministry of Health to launch the Heath Advocacy Network of Timor-Leste (REBAS- TL).

This brief shares insights from LHSS’s review of Timor-Leste’s thriving landscape of civil society organizations (CSOs), with a focus on those that are active in the health sector.

This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.